Related Experiment Video
Updated: Dec 29, 2025

09:15
Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
Published on: May 23, 2014
23.5K
Inhibition of Hyaluronic Acid Synthesis Decreases Endometrial Cell Attachment, Migration, and Invasion
Jessica E McLaughlin1, Marlen Tellez Santos1, Peter A Binkley1
1Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, MC 7836, San Antonio, TX, 78229, USA.
Reproductive Sciences (Thousand Oaks, Calif.)
|February 5, 2020
Summary
4-methylumbelliferone (4-MU) reduces endometrial cell adhesion, migration, and invasion to mesothelial cells by decreasing hyaluronic acid synthases (HAS) and CD44. This suggests 4-MU may be a potential therapeutic for endometriosis.
Area of Science:
- Reproductive Biology
- Cell Biology
- Biochemistry
Background:
- Endometriosis involves endometrial cell adhesion, migration, and invasion.
- The hyaluronic acid (HA) system, including HA synthases (HAS) and CD44, plays a role in these processes.
- 4-methylumbelliferone (4-MU) is investigated for its effects on the HA system and cell behavior.
Purpose of the Study:
- To investigate the impact of 4-MU on the HA system in endometrial cells.
- To determine 4-MU's effect on the attachment, migration, and invasion of endometrial cells to peritoneal mesothelial cells.
- To explore 4-MU as a potential therapeutic agent for endometriosis.
Main Methods:
- In vitro study using human endometrial epithelial cells (EECs) and stromal cells (ESCs).
- Treatment with 4-MU or vehicle, followed by assessment of HA system gene and protein expression (HAS, hyaluronidase, CD44) via RT-PCR and Western blot.
- Evaluation of cell attachment, migration, and invasion assays using standard in vitro techniques.
Main Results:
- 4-MU significantly decreased mRNA and protein expression of HAS 2, HAS 3, and CD44 in EECs and ESCs.
- Treatment with 4-MU reduced the attachment, migration, and invasion of EECs and ESCs to peritoneal mesothelial cells (PMCs).
- The observed effects of 4-MU were correlated with decreased expression of HAS 2, HAS 3, and CD44.
Conclusions:
- 4-MU inhibits endometrial cell adhesion, migration, and invasion to PMCs.
- This inhibition is likely mediated by the downregulation of HAS 2, HAS 3, and CD44.
- 4-MU demonstrates potential as a therapeutic agent for endometriosis, warranting further in vivo investigation.

